Close Menu

Personalis

GeneTalk, an informatics startup based in Berlin, is hoping to make its bread and butter by providing customers with algorithms to prioritize disease variants and a forum through which they can find additional information about these variants from others in the community.

By Uduak Grace Thomas
This article has been updated to correct errors in the previously reported modifications made to BreakSeq — one of the components of the HugeSeq pipeline

By Uduak Grace Thomas
Cartagenia this week released a version of its Bench Lab software that is geared toward analyzing next-generation sequence data in clinical laboratories.

By Monica Heger
This story was originally published Jan. 9.
Knome has hired a new CEO as part of its strategy to expand its whole-genome sequence interpretation services into the clinic.

By Uduak Grace Thomas
As genome sequencing continues to makes inroads into clinics, established vendors and small startups are honing their informatics portfolios to tap into the growing market for software in this setting.

Pairings: Sep 28, 2011

Premium

Martin Madaus has been named Quanterix's permanent CEO. Madaus, who is chairman of the company, had been serving as interim CEO since May when David Okrongly left the Cambridge, Mass.-based company.

Andrew Feinberg, director of the Center for Epigenetics at the Institute for Basic Biomedical Research at Johns Hopkins University School of Medicine, has been awarded a Director's Pioneer Award by the National Institutes of Health.

Martin Madaus has been named as Quanterix's permanent CEO. Madaus, who is chairman of the company, had been serving as interim CEO since May when David Okrongly left the Cambridge, Mass.-based array company.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.